The mechanisms that may operate in spontaneous autoimmune disease are shown diagrammatically in Fig 1. The nature of the initiating stimulus is not known but it may be assumed that it causes activation and proliferation of lymphoid cells with immunological activity directed against autologous target cells. There is much evidence to suggest that tissue damage in most types of autoimmune disease is effected by contact between activated lymphoid cells and target cells, and that the antitissue antibodies that can be detected are a result and not a cause of the disease process. However, circulating antibody undoubtedly plays a part in autoimmune himolytic anemia and may do so in some other conditions, for instance, myasthenia gravis, thyrotoxicosis and eczema (Roitt & Doniach 1967 , Parish et al. 1965 Experiments in vitro show that lymphocytes from individuals with ulcerative colitis, multiple sclerosis and disseminated lupus can attach to appropriate target cells and damage or kill them (Perlmann & Broberger 1963 , Berg & Kallen 196i, Trayanova et al. 1966 ). However, the target cells in these experiments were obtained from other individuals or even from other species and the possibility of homograft or xenograft reactions cannot be dismissed until such experiments are repeated using autologous target cells.
Once under way, an autoimmune process may be partly self-perpetuating. On the one hand, damage to target cells releases antigen which may further stimulate autoimmune activity. On the other hand, damage to target cells may be exacerbated by a local inflammatory reaction.
There are thus many points at which immunosuppressive agents can interfere with autoimmune processes. Activation oflymphoid cells: Little is known about the way in which lymphoid cells come to be specifically activated. There is evidence in the case of humoral antibody production that this step may require the mediation of macrophages and that such mediation may be impaired by radiation (Gallily & Feldman 1967 , Pribnow & Silverman 1967 . It is not known, however, whether macrophage mediation is necessary in autoimmune processes. It is also conceivable that nonspecific activation of lymphoid cells might interfere with their activation by a specific stimulus. Levey & Medawar (1966) have suggested antilymphocyte serum might act in this way. Cell proliferation: Perhaps the most vulnerable step in most types of immune response is the proliferation of lymphoid cells. In spite of the very wide range of biochemical effects produced by immunosuppressive agents, most of them have in common the ability to impair cell reproductive integrity when given in therapeutic doses. This may be the principal way in which many of the standard immunosuppressive agents act (Berenbaum 1967) .
Some agents, particularly radiation, corticosteroids, alkylating agents and actinomycin, also cause rapid death and disintegration of smail lymphocytes, but the relation of this property to their immunosuppressive activity is not clear. Contact destruction: It seems reasonable to suppose that the adherence of lymphoid to target cells is due to the presence of antibody-like configurations on the surface of the former. If this is so, we would not expect any of the usual immunosuppressive agents to prevent adherence because they do not inhibit antigen-antibody combination. In fact, only heparin has so far been found to prevent attachment in vitro (Taylor & Culling 1966 ) and none of the standard immunosuppressive agents so far tested does so. However, the damage caused after adherence has taken place appears to require metabolic activity by the activated cell and it can be reduced or prevented in vitro by azathioprine and actinomycin, which inhibit nucleic acid synthesis, and by chloramphenicol, which inhibits protein synthesis (Wilson 1965 , Granger & Weiser 1966 . Damage Kidson 1967) or by stabilizing cell and lysosomal membranes in the target cell, the attacking cell or both. Humoral mechanisms: Target cell damage caused by antibody and complement can be reduced if antibody production is inhibited. The immunosuppressive agents shown to inhibit antibody production in man include 6-mercaptopurine, azathioprine, cyclophosphamide, methotrexate and 5-fluorouracil (Levin et al. 1964 , Maibach & Epstein 1965 , Santos et al. 1964 , Hersh et al. 1965 , Hersh, Carbone & Freireich 1966 , Bowen et al. 1966 . The corticosteroids form an interesting exception. In therapeutic doses, they have not been found to inhibit the production of antibody to bacterial or viral antigens in man (Larson & Tomlinson 1951 , Mirick 1951 , Friedman 1953 , Kunin et al. 1959 ). However, they reduce the titre of antibodies to red cells in autoimmune hemolytic anmmia (Dameshek & Komninos 1956 , Dacie 1962 ) and the titre of antistreptolysin 'O' and serum gamma globulin levels in acute rheumatic fever (Stolzer et al. 1954 , Harris et al. 1956 ). As steroid therapy does not appear to inhibit production of antibody to exogenous antigens in man, it is possible that their effect on antibodies in autoimmune diseases is indirect and due to interruption of the selfperpetuating pathogenic mechanisms discussed above. On the other hand, these conflicting observations might be explained by the supposition that it is easier to suppress antibody production to the relatively weak antigens involved in autoimmunity than to the highly antigenic materials obtained from bacteria and viruses.
Antibody alone may cause surface changes and lysosomal activation in target cells but does not seriously impair their viability. Antibody and complement together may kill target cells, probably by puncturing first the cell membrane and then various intracellular membranes (Dumonde et al. 1965) . A reduction in serum complement activity might therefore be expected to reduce antibody-mediated damage in autoimmune disease. However, of the standard immunosuppressive agents, only the corticosteroids have been shown to lower complement activity in vivo, and this only in mice (Caren & Rosenberg 1966) . Corticosteroids have not been found to have a convincing effect on complement levels in other species, nor do the majority of other immunosuppressive agents have this effect. Inflammation: It is well known that the corticosteroids powerfully suppress both the vascular and cellular components of the inflammatory response. In man, this suppression is so marked and effects on antibody production are so dubious, that it is commonly supposed that the effectiveness of corticosteroids in autoimmune disease is due entirely to their anti-inflammatory actions. In our present state of ignorance it is impossible to disprove this, but it seems unwise to attribute the effectiveness of steroids to this one mechanism in view of their known effects on macrophage activity, lymphoid cell metabolism and cell membrane integrity.
It is also becoming clear that some other potent immunosuppressive agents have anti-inflammatory effects. These include 6-mercaptopurine, methotrexate and actinomycin (Page & Good 1962 , Borel & Schwartz 1964 , Ward et al. 1964 , Page 1965 , Hersh, Wong & Freireich 1966 ). This effect is characteristically shown by failure of mononuclear cells to migrate into sites of inflammation, even when peripheral blood leucocyte levels are normal.
It is interesting that antilymphocyte serum has a similar effect on polymorphonuclear leucocytes, reducing their ability to migrate into sites of inflammation without causing a peripheral blood neutropenia (Waksman et al. 1961 , Turk & Willoughby 1967 .
The inflammatory response may also be inhibited indirectly by agents, such as radiation or nitrogen mustard, that interfere with cell proliferation and cause leucopenia, thus reducing the population of cells that participate in inflammatory reactions.
Chloroquine and epsilon aminocaproic acid both ameliorate the course of autoimmune disease (Merwin & Winkelmann 1962 , Wuthrich et al. 1963 ) and have anti-inflammatory effects (Winter & Nuss 1966) . They do not inhibit antibody production and it has been suggested that some of their effects may be due to an anticomplementary action (Neblett et al. 1965 , Zukoski et al. 1965 .
Whatever the cause of the anti-inflammatory effect, it is evident that it may directly alleviate the manifestations of autoimmune disease. It may also act indirectly by interrupting selfperpetuating mechanisms maintaining the disease process.
Conclusion
We have hardly begun to disentangle the various mechanisms involved in the actions of immunosuppressive agents in autoimmune disease. In view of the multiple actions of these agents and the multiple mechanisms operating in autoimmune disease, it is not suprising that what is essentially a blunderbuss therapy sometimes hits the target.
These successes should not mislead us into believing that we know which action has produced the desired effect, nor even that we know what the target is that we have hit. Nitrogen mustard was first used in the treatment of the nephrotic syndrome eighteen years ago (Chasis et al. 1949) but was soon to be superseded by corticosteroids. After more than fifteen years, however, it has become apparent that steroid therapy is by no means a perfect treatment for children with the nephrotic syndrome. In a tenyear follow-up study Cornfeld & Schwartz (1966) found that the mortality approached 25 %. Arneil & Lam (1966) recently reported their findings in 45 nephrotic children treated with prednisolone and followed up for not less than five years. Fiftythree per cent of patients relapsed after initially responding to treatment and 7 % failed to respond at all. Unfortunately they were unable to correlate the steroid response in their patients with either the selectivity of proteinuria (Cameron & White 1965) or renal biopsy findings. They did, however, observe a greatermortality and incidence of persistent proteinuria in children who had macroscopic heematuria at onset. Such patients often have a serious form ofproliferative glomerulonephritis (GN) and, because they may actually be harmed by steroid therapy (White et al. 1966) , it is desirable that a complete diagnosis should, whenever possible, be made before starting treatment.
Renal Morphology and Steroid Response
While it is not the purpose of this paper to discuss at length the renal morphology in the nephrotic syndrome, a brief reference is nevertheless appropriate, since the patterns of steroid response are related to the glomerular changes. Table 1 shows the findings in renal biopsy specimens obtained from 136 children by Dr J S Cameron and myself, all of them examined personally by light microscopy. They will be published in detail--in a later paper. Seventy-eight children were biopsied before treatment and form an unselected series. The remaining 58 children were referred on account of diagnostic or therapeutic problems, and include a high proportion of patients with severe proliferative and chronic GN.
Some of the patients are participants in a controlled investigation of -steroid therapy which precludes detailed interim analysis, and follow-up data are at present incomplete. However, from information derived from 93 of the 136 children certain generalizations can be made. There appears to be no distinction, other than on histological grounds, between patients showing 'minimal changes' and those showing mild proliferative GN. Indeed it is sometimes difficult to place an individual biopsy specimen confidently in either category, and two pathologists will often hold different opinions. The clinical presentations 
